A Phase 1 Study of Trametinib in Combination With Radiation Therapy for Brain Metastases
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Trametinib (Primary)
- Indications Brain metastases
- Focus Adverse reactions; Pharmacokinetics
- 10 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 22 Nov 2016 Status changed from suspended to recruiting.